Finanzwire Finanzwire
Basculer en Français
10604 Companies
225013 Keywords
153734 Articles
119072 Press releases
Headlines Articles Press releases TME PHARMA N.V. Remove
  1. Home
  2. Companies
  3. TME PHARMA N.V.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/23/2024 at 10:54, 1 year 6 months ago

    Inside Information / Other news releases

    TME Pharma presents poster on NOX-A12 inhibition of CXCL12 in glioblastoma at 2024 SNO Annual Meeting, demonstrating enhanced anti-tumor immune responses in brain cancer models
    Glioblastoma TME Pharma NOX-A12 CXCL12 Inhibition SNO Annual Meeting
    Logo of TME PHARMA N.V.
  • BRIEF

    published on 08/12/2024 at 19:05, 1 year 10 months ago

    TME Pharma Increases Allocated Resources for Liquidity Contract

    Liquidity Contract INVEST SECURITIES AMF Decision TME Pharma Share Allocation
  • PRESS RELEASE

    published on 08/12/2024 at 19:00, 1 year 10 months ago

    Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract

    TME Pharma increases resources for liquidity contract with Invest Securities to support cash balance and securities. Details of the update provided in accordance with AMF regulations
    Liquidity Contract Biotechnology INVEST SECURITIES AMF Regulations TME Pharma
    Logo of TME PHARMA N.V.
Previous page
1 2 3
Accesswire
  • Published on 06/20/2026 at 01:00, 1 day 2 hours ago

    Onco-Innovations Announces Non-Brokered LIFE Offering

  • Published on 06/20/2026 at 00:00, 1 day 3 hours ago

    Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

  • Published on 06/19/2026 at 04:30, 1 day 22 hours ago

    Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp

  • Published on 06/19/2026 at 01:20, 2 days 1 hour ago

    American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting

  • Published on 06/19/2026 at 01:07, 2 days 2 hours ago

    Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE
EQS Group
  • Published on 06/20/2026 at 21:25, 5 hours 51 minutes ago

    VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS

  • Published on 06/20/2026 at 06:00, 21 hours 16 minutes ago

    Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong

  • Published on 06/19/2026 at 20:17, 1 day 6 hours ago

    2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations

  • Published on 06/19/2026 at 19:01, 1 day 8 hours ago

    Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

  • Published on 06/19/2026 at 18:29, 1 day 8 hours ago

    Designated Person Notification

View all EQS
Les Echos
  • Published on 06/19/2026 at 19:33, 1 day 7 hours ago

    Disclosure of transactions in own shares from June 15 to June 19, 2026

  • Published on 06/19/2026 at 19:23, 1 day 7 hours ago

    Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026

  • Published on 06/18/2026 at 18:00, 2 days 9 hours ago

    Outstanding shares and voting rights statement at 31 May 2026

  • Published on 06/18/2026 at 17:45, 2 days 9 hours ago

    EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE

  • Published on 06/18/2026 at 17:38, 2 days 9 hours ago

    Statement of transactions in own shares from June 8, 2026 to June 12, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy